SERPINE1 and steatosis: In conclusion, metformin may prevent and reverse steatosis and inflammation in a nondiabetic mouse model of steatohepatitis possibly by downregulating pleiotropically lipogenic and fibrogenic genes such as Serpine1 without affecting insulin resistance.